Literature DB >> 11238438

Cost and cost-effectiveness guidelines: which ones to use?

D Walker1.   

Abstract

Given the increased awareness of the importance of cost-effectiveness in health care, there has been a growth in the number of published economic evaluations in recent years. Partly in response to concerns about deficiencies in the methodology of published studies, there has been a growth of interest in guidelines for economic evaluation. This paper reviews the various objectives of economic analyses, and then summarizes the existing groups of guidelines for cost and cost-effectiveness analyses. Finally, it compares and discusses the appropriate uses and limitations of the guidelines, with particular emphasis on those developed for applications in developing countries.

Mesh:

Year:  2001        PMID: 11238438     DOI: 10.1093/heapol/16.1.113

Source DB:  PubMed          Journal:  Health Policy Plan        ISSN: 0268-1080            Impact factor:   3.344


  23 in total

1.  Cost-effectiveness analysis: a proposal of new reporting standards in statistical analysis.

Authors:  Heejung Bang; Hongwei Zhao
Journal:  J Biopharm Stat       Date:  2014       Impact factor: 1.051

2.  Integrated surveys of neglected tropical diseases in southern Sudan: how much do they cost and can they be refined?

Authors:  Jan H Kolaczinski; Kara Hanson; Emily Robinson; Diana Picon; Anthony Sabasio; Martin Mpakateni; Mounir Lado; Stephen Moore; Nora Petty; Simon Brooker
Journal:  PLoS Negl Trop Dis       Date:  2010-07-13

3.  Evaluating the cost-effectiveness of universal hepatitis B virus vaccination in Iran: a Markov model analysis.

Authors:  Ali Mohammad Mokhtari; Mohsen Barouni; Mohsen Moghadami; Jafar Hassanzadeh; Rebecca Susan Dewey; Alireza Mirahmadizadeh
Journal:  Hum Vaccin Immunother       Date:  2021-03-18       Impact factor: 3.452

4.  The cost of antibiotic mass drug administration for trachoma control in a remote area of South Sudan.

Authors:  Jan H Kolaczinski; Emily Robinson; Timothy P Finn
Journal:  PLoS Negl Trop Dis       Date:  2011-10-11

5.  Basing care reforms on evidence: the Kenya health sector costing model.

Authors:  Steffen Flessa; Michael Moeller; Tim Ensor; Klaus Hornetz
Journal:  BMC Health Serv Res       Date:  2011-05-27       Impact factor: 2.655

6.  Scaling up health intervention: is planning in Nigeria becoming evidence based?

Authors:  Babayemi Oluwaseun Olakunde
Journal:  Pan Afr Med J       Date:  2011-10-03

7.  Costing interventions in the field: preliminary cost estimates and lessons learned from an evaluation of community-wide mass drug administration for elimination of soil-transmitted helminths in the DeWorm3 trial.

Authors:  Katya Galactionova; Maitreyi Sahu; Samuel Paul Gideon; Saravanakumar Puthupalayam Kaliappan; Chloe Morozoff; Sitara Swarna Rao Ajjampur; Judd Walson; Arianna Rubin Means; Fabrizio Tediosi
Journal:  BMJ Open       Date:  2021-07-05       Impact factor: 2.692

8.  Empirical evidence of the continuing improvement in cost efficiency of an endoscopic surveillance programme for gastric cancer in Singapore from 2004 to 2010.

Authors:  Hui Jun Zhou; Shu Chuen Li; Nasheen Naidoo; Feng Zhu; Khay Guan Yeoh
Journal:  BMC Health Serv Res       Date:  2013-04-15       Impact factor: 2.655

9.  Economic evaluations of non-communicable disease interventions in developing countries: a critical review of the evidence base.

Authors:  Jo-Ann Mulligan; Damian Walker; Julia Fox-Rushby
Journal:  Cost Eff Resour Alloc       Date:  2006-04-03

10.  Programme costs in the economic evaluation of health interventions.

Authors:  Benjamin Johns; Rob Baltussen; Raymond Hutubessy
Journal:  Cost Eff Resour Alloc       Date:  2003-02-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.